Pharmaceuticals Policy in the EU

Latest business news about Pharmaceuticals and Medicines Policy in the European Union

Forum assesses competitiveness of Europe's pharmaceutical industry — 06 October 2008, 23:10 CET

Europe's Pharmaceutical Forum has concluded its three-year process and, on 2 October, put forward several recommendations addressing the many challenges facing the pharmaceutical industry, public health interests and national healthcare systems.

Drug company Merck posts second quarter growth despite strong euro — 23 July 2008, 13:28 CET

The German pharmaceutical and chemical group Merck posted Wednesday strong second quarter results despite negative foreign exchange effects, it said in a statement.

First call for Innovative Medicines Initiative a success — 23 July 2008, 00:19 CET

The first stage of calls for the Innovative Medicines Initiative (IMI), which is supported by the EU with EUR 1 billion in funding, was recently closed and is already being regarded as a success by many of those involved.

European regulators approve breast cancer drug: GSK — 12 June 2008, 19:44 CET

British pharmaceutical firm GlaxoSmithKline said on Thursday that European regulators had given marketing approval for its tablet breast cancer drug Tyverb.

EU targets Sanofi-Aventis over obstruction of anti-trust probe — 02 June 2008, 17:11 CET

The Commission has opened an investigation into whether French pharmaceutical group Sanofi-Aventis obstructed an inspection of its premises.

First EU licence granted for pre- pandemic bird flu vaccine — 19 May 2008, 12:22 CET

The European Commission has granted the first licence to market a vaccine in preparation for a pandemic of H5N1 bird flu in Europe.

Innovative Medicines Initiative boost for Europe's pharmaceutical industry — 06 May 2008, 01:00 CET

With the launch of its first call for proposals, the Innovative Medicines Initiative (IMI) got underway on 30 April. Joining forces, the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) hope to bring Europe back to the forefront of medical innovation.

European Commission targets Germany over pharmacy rules — 02 February 2008, 16:28 CET

The European Commission has initiated infringement proceedings against Germany over its restrictions on the ownership of pharmacies.

Top European pharma firms confirm EU antitrust probe — 16 January 2008, 15:09 CET

Anglo-Swedish drugs giant AstraZeneca and British peer GlaxoSmithKline said Wednesday they had been approached by EU regulators as part of an antitrust probe into the pharmaceutical sector.

Antitrust sector inquiry into pharmaceuticals - guide — 16 January 2008, 12:49 CET

News, background information and web links about European Union policies on pharmaceuticals and medicines.

EU launches antitrust probe into pharmaceutical sector — 17 January 2008, 18:41 CET

The European Commission said Wednesday it had launched an antitrust probe into the pharmaceutical industry on concerns about uncompetitive behaviour in the sector.

Access to essential medicines — 19 November 2007, 17:22 CET

Infectious diseases are responsible for almost half of all deaths in developing countries, and half of these diseases are caused by HIV (AIDS), tuberculosis and malaria. More than 2 billion inhabitants of the world do not have regular access to adequate treatment and cure. AIDS, tuberculosis and malaria alone kill 5 million people each year mostly in developing countries.

WTO deal on generic medicines - guide — 19 November 2007, 17:17 CET

News, background information and web links about the trade policy of the European Union.

2007 Annual report from the EU drugs agency — 08 November 2007, 19:49 CET

Drug facts, figures and analyses: across Europe and by country - Latest trends and legal, political, social and health responses - Selected issues: Drugs and driving; drug use among the under 15s; cocaine

EU Commission launches consultation on pharmaceuticals — 03 August 2007, 22:10 CET

The European Commission has launched a consultation on the future of pharmaceuticals for human use in Europe, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for pharmaceuticals.

Innovative Medicines Initiative Online — 16 May 2007, 12:46 CET

The Innovative Medicines Initiative is a proposed partnership between the European Commission and the European Federation of Pharmaceutical Industry and Associations (EFPIA). The vision of IMI is to create Biomedical Research & Development leadership for Europe to benefit patients and society.

Faster access to better medicines: the Innovative Medicines Initiative — 16 May 2007, 12:48 CET

News, background information and web links about the public health policy of the European Union.

EMEA issues guidelines on clinical trials for high-risk drugs — 28 March 2007, 14:50 CET

The European Medicines Agency (EMEA) has adopted draft guidelines for first-in-man clinical trials of potentially high-risk medicinal products.

Pharmaceuticals in the EU — 25 August 2006, 11:35 CET

News, background information and web links about European Union policies on pharmaceuticals and medicines.

EU Pharmaceuticals portal — 08 August 2006, 09:42 CET

Since 1985, a score of European Community directives have been adopted with the aim of achieving a single, EU-wide market for pharmaceuticals.

European cosmetics industry — 03 January 2007, 17:44 CET

The European cosmetics industry has a value of output of more than EUR 35 billion; is highly innovative, with major cosmetic companies replacing or reformulating around 25% of their products every year; and employs over 150.000 Europeans directly, with a further 350.000 jobs created indirectly in retail, distribution and transport. The main regulatory framework which aims at ensuring the free circulation of cosmetic products in the internal market and safeguarding the safety of cosmetic products placed on the EU-market is the Council Directive 76/768 of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products ("Cosmetics Directive").

Medicinal products register — 08 August 2006, 09:33 CET

European Community register of medicinal products for human use

EU Directive on Dangerous Substances — 07 August 2006, 16:54 CET

Ehe EU Directive on Dangerous Substances was a response to a need to ensure the protection of public health, in particular the health of workers handling dangerous substances.

European Agency for the Evaluation of Medicinal Products - EMEA — 19 July 2007, 20:22 CET

The European Agency for the Evaluation of Medicinal Products (EMEA) is a decentralised body of the European Union. It has its headquarters in London since January 1995. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.

EU trade - access to essential medecines — 05 August 2006, 22:08 CET

Infectious diseases are responsible for almost half of all deaths in developing countries, and half of these diseases are caused by HIV (AIDS), tuberculosis and malaria. More than 2 billion inhabitants of the world do not have regular access to adequate treatment and cure. AIDS, tuberculosis and malaria alone kill 5 million people each year mostly in developing countries. European Union initiatives